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before and after RT-3D image denoising using multiscale brushlet analysis. 
Methods: Two-dimensional and RT-3D echocardiography and tomographic MRI were 
performed in 10 patients with PPH. The RT-3D volumes ware then processed by the spa- 
tio-temporel denoising technique using 4D (3D+Time) brushier analysis and measured 
separately. Brushlet analysis was applied for denoising of speckle components and 
enhancement of coherent spatial and temporal anatomical structures. Patient age 
ranged from 8 yrs to 63 yrs (median 43 yrs). RV volume was calculated by 3 methods of 
2D echocardiography: 1) modified biplane pyramidal approximation, 2) monoplane ellip- 
soid approximation, and 3) Simpson's summation of discs. RV volumes were calculated 
with RT-3D eohocardiography by the sector plane-disks summation method both before 
and after the spetio-temporal denoising technique. Cardiac MRI was performed on 1.5T 
GE (Madison, Wl) magnet utilizing a torso coil. Breath-hold FSP GR cine images cover- 
ing the complete R-R cycle in short axis were obtained. 
Results: The MRI RV end-diastolic volumes ranged from 90 to 3tlcc and the RV end- 
systolic volumes ranged from 63cc to 269cc. The RV ejection fraction ranged from 9% to 
54%. The best correlation with MRI for RV ejection traction was obtained by the denoisad 
3D technique (r=0.91) compared to the 3D technique without denoising (r=0.63) and to 
all 2D techniques (r value ranged from 0.62 to 0.78). 
Conclusion: The estimation of RV function by RT-3D ultrasound with 4D brushlet analysis 
is superior to 2D methods in PPH patients. This denoising technique appears to be use- 
ful in overcoming the spatial resolution limitations of RT-3D ultrasound. 
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Induction of Angiogenesis In e Canine Model of Chronic 
Myocardial Ischernle With Intravenous Infusion of 
Vascular Endothelial Growth Factor (VEGF) Combined 
With Ultrasound Energy and Echo Contrast Agent 
Zhonamin Zhou. Debebrata Mukherjee, Kai Wang, Xiarong Zhou, Khaldoun Tarakji, Keith 
Ellis, Albert W. Chan, Marc S. Penn, Jonny Oetensen, James D. Thomas, Mario Garcia, 
Eric J. Topoi, Stephen G. Ellis, Cleveland Clinic Foundation, Cleveland, Ohio, University 
of Michigan, Ann Arbor, Michigan. 
Background: A major limitation of VEGF for therapeutic angiogenesis is the need for 
direct myocardial injection. The objective of this study was to determine whether intrave- 
nously administered VEGF given in conjunction with ultrasound(US) and albumin based 
ultrasonic contrast agent (C) could induce angiogenesis in a canine model of chronic 
myocardial ischemia. Methods: We used an ameroid-induced coronary occlusion model 
and randomized animals to one of four regimens: Placebo (Saline); VEGF alone; VEGF 
+ US; and VEGF + US + C. VEGF was given intravenously once a week for 4 weeks after 
coronary occlusion. Continuous wave Doppler ultrasound (1.2 watts/sq.cm at 1 MHz) 
was applied to the chest wall overlying the myocardium during infusion of VEGF (17ng] 
kg/minute) mixed with 0.1% C (Sonazoid, Nycomed Imaging AS, Oslo). Myocardial blood 
flood was determined with colored microspheres. Endothelial cells were detected by Fac- 
tor VIII immunostaining, and infarct area measured by TTC staining, Results: The com- 
bination of VEGF + US + C significantly reduced infarct area/risk area ratio, markedly 
increased myocardial blood flow in the ischemic territory and increased endothelial cells 
in ischemic territory. Conclusions: These results demonstrate that intravenous VEGF 
given in conjunction with ultrasound and ultrasonic ontrast agent can induce angiogene- 
sis in a canine model of chronic myocardial ischemia and suggest a potential new thera- 
peutic approach for angiogenssis. 
Saline VEGF VEGF + US VEGF+US+C pvalue 
(n=6) (n=3) (n=3) (n=6) 
Infarct/Riskarea 0.16±0.02 0.12±0.03 0.11 ±0.02 0.06±0.02* 0.01 
Change in blood flow -34% ± 23% -28% ± 10% -0.37 ± 24% +52% ± 32%* 0.001 
Endothelialcellcount 18.03±0.92 14.80±0.50 19.00±1.11 25.45±0.26* 0.02 
10:45 a.m. 
894-2 Novel Acoustic Azithromycln-Encapsulsted Liposomes 
Inhibit Chlamydial Growth In Endothelial Cells 
Susan D. Tiukinhov, Amer Khan, Shaoling Huang, Robert C. MacDonald, David D. 
McPherson, Northwestern Universi~ Chicago, Illinois. 
The role of infection in atherescleresis and the therapeutic use of antibiotics are being 
investigated. A major ccncem is the nonspeoific targeting of cells by systemic drug deliv- 
ery. We have developed novel acoustic liposomes that can be antibody conjugated for 
directed tissue enhancement. We have shown encapsulation of azithromycin into these 
liposomes with retention of acoustic and stability properties. This study aimed to demon- 
strate the effect of these drug-loaded liposomes on Chlamydial growth in cultured cells. 
Methods: Lipoeomss were made and azithrornycin was added to the lipid film before 
rehydration. Human umbilical arterial endothelial cells were infected with C. pneumoniae 
at 20 multiplicities of infection. After 2 hours, the calls were treated with empty liposomes, 
~.ithromycin-lcaded Ubosomes, free azlthromycin, or media (control). After 72 hours, 
infection-forming units were counted using fluorescence techniques. 
Results: Treatment with azithromycin-loeded liposomes inhibited Chlamydial growth in 
cultured cells (p < 0.001). This effect was not different from free azithromycin (p = 1.0), 
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but significantly different from empty liposomes (p < 0.001). 
Conclusion: We have developed novel acoustic liposomes that can encapsulate 
azithromycin and inhibit Chlamydial growth in cultured endothelial cells. Drug encapsula- 
tion using our acoustic antibody conjugated liposomes provides exciting potential for tar- 
geted drug delivery and site-specific therapies for atharosclerosis. 
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894-3 Effect of Unfocused Trenecrental Low Frequency 
Ultrasound end Perf luorocarbon Microbubbles on 
Dissolving Multiple Intracranial Thrombi 
Todd Tessendorf. Feng Xie, Pierre Fayed, Thomas R. Porter, University of Nebraska 
Medical Center, Omaha, Nebraska. 
Background. Transcranial ow frequency ultrasound (LFUS) and intravenous perfluoro- 
carbon containing microbubbles (PESDA) may be a method of locally dissolving acute 
intracarebral emboli or thrombi in acute ischemic stroke (AIS). Since multiple throm- 
boemboli (TE) often occur simultaneously in AIS, we hypothesized that an unfocusad 
LFUS transducer should be able to racanalize multiple intracranial thrombi at different 
depths and elevation planes within the cranium. Methods. Pulsed wave LFUS (1 mega- 
hertz or 40 kilohertz) was applied transtamporally for ten minutes across a human skull 
containing tissue mimiking material and three intravascular thrombi (formed from venous 
blood from four healthy volunteers) placed at different depths (proximal location 3.5 cm, 
deep location 6.0 cm behind temporal bone) and elevation planes (0.5 cm above proxi- 
mal vessel) within the cranium. PESDA or saline!0.2 ml every two minutes x 4) was 
injected into a 3.4 mm diameter tube flowing at 35 ml/min proximal to the tdfurcation of 
the three intracranial vessels. Results. Both 40 KHz and t MHz LFUS with PESDA pro- 
ducad significantly greater simultaneous thrombus dissolution than either frequency 
alone, even in the thrombosed vessels at deeper depths (Table; *p<0.01 compared to 
LFUS alone). Conclusions. Transtemporal unfocused pulsed wave LFUS could be an 
ideal therapy for dissolving simultaneously the multiple intravascular TE that are respon- 
sible for brain damage in AIS. 
Percent Reduction in Multiple Intracranlal Thrombl 
with Ultrasound and Miorobubbles 
USAIone 1 MHz US_+ PESDA 40 KHz US + PESDA 
Proximal Thrombus % Dissolution 2+9% 21+10%* 19-J:7%* 
Deep Thrombus % Dissolution 4+_17% 23+13%* 25:t:4%* 
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894-4 Echocardiogrephic Detection and Quantif ication of 
Early Left Ventriculer Hypertrophy After Aortic Banding 
in Mice 
Justina C. Wu, Fumito Ichinose, Kenneth D. Bloch, Michael H. Picard, Marielle Scherrer- 
Crosbie, Massachusetts General Hospital, Boston, Massachusetts. 
Background: Transthoracic echocardiography offers a noninvasive method of evaluating 
alterations in cardiac structure and function in mouse models of heart disease. However, 
the accuracy of ultrasonogrephy in measuring the early cardiac response to increased 
wall stress has not been validated in mice. 
Methods: Left ventdcular (LV) size, wall thickness, mass, and systolic function were eval- 
uated by echocardiography in C57BL6 mice (n=8) at baseline and 1 week after induction 
of pressure ovedoad which was achieved by banding of the transverse aortic arch. 
Hamodynamic parameters, LV weights, and cardiomyocyte widths were compared in 
unbanded (n=5) and banded mica. 
Results: Aortic banding induced an immediate pressure gradient across the aortic arch, 
which was sustained at a mean of 24±6.4 mm Hg at day 7 post-operatively. Echocardio, 
graphy revealed a 44% concentric increase in LV wall thickness, as measured in both the 
anterior (from 0.50¢0.005 mm to 0.72±0.03 mm) and posterior walls (from 0.59±0.03 mm 
to 0.85±0.02 mm, p<0.003 for both segments). There was no significant LV dilation or 
change in ejection fraction at the 7 day time point. Hemodynamic measurements howed 
no significant change in LV end-diastolic pressure (LVEDP), although the maximum dP/dt 
decreased from 12097±702 mm Hg/s to 8600±982 mm Hg/s (p<0.03) by 7 days. The LV 
mass/body mass ratio in the banded mice was 46% greater compared to that of 
unbanded mice (4.53±0.3 mg/g in banded mice vs. 3.11±0.06 mg/g in unbanded con. 
trois, p=0.003). There was a significant correlation (r2=0.62, p=0.02) between true LV 
mass and LV mass calculated by echocardiography. Histology of the excised hearts 
revealed that the average cardiomyocyta wLdth increased from 17.6±0.6 pm in unbanded 
mice to 21.4±0.4 ~m (22% increase, p=0.0005) in banded animals. 
Conclusion: In mice. echocardiography can reliably detect and quantltate ady patholog- 
ical responses of the heart to increased aftedoad, prior to the onset of overt LV dilation 
and decompensation. 
